Labiotech.eu

Opinion 18 Jan 2023

Innovation in life sciences requires collaboration and community

By Claudia Tripp and Katie Nelson, Kadans Science Partner Collaboration has underpinned some of the most impactful innovations of recent years. For example, the rapid development of the COVID vaccine was only made possible due to collaboration. Pfizer’s rapidly-established partnership with BioNTech delivered the first vaccine at lightning speed. Having established an ecosystem approach to […]

January 18, 2023 - 5 minutesmins - By External Contributor

News and Trends 18 Jan 2023

BioInvent receives funding for blood cancer treatments

BioInvent International AB has been selected as partner of The Leukemia & Lymphoma Society’s Therapy Acceleration Program (LLS TAP). The program is aimed at advancing the company’s program to treat blood cancers. The partnership will include access to the scientific, clinical and drug development expertise of LLS as well as a strategic capital equity investment […]

January 18, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 18 Jan 2023

Funding for industry-first cancer screening technology

Medicines Discovery Catapult (MDC) and SMi have secured a Biomedical Catalyst (BMC) grant to validate a new approach to detect cancer biomarkers. It will transform their use for routine cancer screening and enable monitoring of treatment efficacy in real time. Liquid biopsies are where a simple blood sample is analyzed for tiny quantities of cancer-related […]

January 18, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 18 Jan 2023

Vésale Bioscience receives €1.8M grant for AMR phage project

Belgian company Vésale Bioscience has received €1.8 million ($1.9 million) in grants from the European Innovation Council (EIC) Accelerator Fund for its PhageDiag project, a phagogram using artificial intelligence that enables decentralized diagnostics and personalized treatment. According to the World Health Organization (WHO), antimicrobial resistance (AMR) is one of the top 10 global public health […]

January 18, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 17 Jan 2023

Is Copenhagen the world capital of life science?

Denmark’s leading life science companies, public foundations, municipalities, universities and hospitals will work together to position Copenhagen as the world capital of life science through the newly-launched Copenhagen Life Science partnership. Tackling obesity is the first step in this public-private partnership. In 2022, the Danish government invested 82 million DKK ($11.7 million) to strengthen and […]

January 17, 2023 - 4 minutesmins - By Jim Cornall

In Depth 17 Jan 2023

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the globe, and a growing number are choosing the Swiss city of Basel as their base. These companies are taking advantage of the talent pool, academic institutions and investors that the area has to offer, culturing […]

January 17, 2023 - 5 minutesmins - By External Contributor

Colombia Foodtech Acceleration Program Startups

News and Trends 17 Jan 2023

Colombia foodtech acceleration program includes startups in first cohort

The Colombia Foodtech Acceleration Program has started its first edition led by Vertical-I, Centre of Excellence in Innovation Systems in Colombia, in alliance with agrifood accelerator Eatable Adventures. The program aims to develop and strengthen the agri-food industry ecosystem in Colombia, which is known as the “Innovation Hub of Latin America.” According to the Organisation […]

January 17, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 17 Jan 2023

Ascletis phase I COVID trial progressing

Ascletis Pharma Inc. has announced the dosing of four healthy subjects in its multiple-dose escalation phase I clinical trial of oral 3-chymotrypsin like protease (3CLpro) inhibitor ASC11 in combination with 100 mg ritonavir tablets for COVID-19. The phase I clinical trial is expected to enroll 72 healthy subjects, including 60 subjects in single-dose escalation cohorts […]

January 17, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 17 Jan 2023

Poolbeg expands POLB 001 into oncology

Poolbeg Pharma has announced the strategic expansion of POLB 001 into oncology. POLB 001 is a strain agnostic, small molecule immunomodulator being studied to address the unmet medical need for a treatment for severe influenza. While investigating the role of cytokine release syndrome (CRS) in severe influenza, Poolbeg discovered data specific to the overt immune […]

January 17, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 17 Jan 2023

Multus Biotechnology closes $9.5M funding to bring cultivated meat closer to price parity

Multus Biotechnology Limited, a U.K.-based start-up creating ingredients for the affordable scale-up of cellular agriculture, has completed a £7.9 million ($9.5 million) funding round led by Mandi Ventures. Other investors include SOSV, Big Idea Ventures and SynBioVen, alongside Asahi Kasei, a global company that contributes to a sustainable society by tackling evolving challenges in materials, […]

January 17, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 17 Jan 2023

EverImmune launches trial for oncobiotic lung and kidney cancer drug candidate

EverImmune, a clinical-stage biotechnology company specialized in the development of live biotherapeutic products in the field of microbiota oncology, says the first patient has been treated in its phase I clinical trial (EV 2101) evaluating Oncobax AK in lung and kidney cancer patients. The aim of the trial is to assess the toxicity and efficacy […]

January 17, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 17 Jan 2023

TTP spinout Cellular Origins to focus on cell and gene therapies

TTP plc, a technology and product development company, has announced the launch of Cellular Origins. Cellular Origins is a TTP spin-out, created to enable scalable, cost-effective and efficient manufacture of cell and gene therapies. Cellular Origins’ proprietary technology addresses the current barriers associated with the manufacture of advanced therapies that are in late-stage development, enabling […]

January 17, 2023 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Innovation in life sciences requires collaboration and community

BioInvent receives funding for blood cancer treatments

Funding for industry-first cancer screening technology

Vésale Bioscience receives €1.8M grant for AMR phage project

Is Copenhagen the world capital of life science?

Cell and gene therapies gain momentum in Basel

Colombia foodtech acceleration program includes startups in first cohort

Ascletis phase I COVID trial progressing

Poolbeg expands POLB 001 into oncology

Multus Biotechnology closes $9.5M funding to bring cultivated meat closer to price parity

EverImmune launches trial for oncobiotic lung and kidney cancer drug candidate

TTP spinout Cellular Origins to focus on cell and gene therapies

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!